Although there are no human clinical trials on optimal dosing, we rely on animal literature and anecdotal evidence
One small retrospective case series investigated intra-articular BPC-157 injections for knee pain but lacked rigorous methodology, control groups, and long-term follow-up ([6])
[41] : 973 Breast milk B 12 decreases over months of nursing in both well-nourished and vitamin-deficient mothers
While these challenges contribute to higher costs and complexity compared to small molecule drugs, solutions continue to emerge that may reduce these barriers over time
AOD-9604 FDA Approval History At a glance FDA approval status / Never approved for any indication in the United States NDA filing history / No New Drug Application has ever been submitted to FDA Chemical identity / Synthetic peptide corresponding to amino acids 176-191 of human growth hormone, with a tyrosine residue added at the C-terminus Developer / Metabolic Pharmaceuticals Ltd (Melbourne, Australia), now defunct Clinical trial outcome / Phase IIb trial (2007) failed to meet primary efficacy endpoint for obesity FDA compounding status / Placed on Category 2 list
BPC-157 is also known as the Wolverine peptide, for its ability to help support repair and recov